Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-05-11 @ 8:12 AM
Study NCT ID:
NCT05962502
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2023-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
Sponsor:
Sun Yat-sen University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NEORAS-SYSUCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None